From: Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development
LCR sequence
potein
LCR start
LCR end
PPDEDEEEGDCEEEEFE
nsp3
108
124
QPEEEQEEDWLDDDSQ
152
167
MLCCMTSCCSCLKGCCSCGSCC
S protein
1233
1254
GSRGGSQASSRSSSRSRNSSRNSTPGSSRGTSP
N protein
175
207
KTFPPTEPKKDKKKKADE
361
378